Cited 0 times in
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김창수 | - |
dc.date.accessioned | 2023-11-07T08:10:29Z | - |
dc.date.available | 2023-11-07T08:10:29Z | - |
dc.date.issued | 2023-09 | - |
dc.identifier.issn | 1759-7706 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/196597 | - |
dc.description.abstract | Background: Higher concentrations of particulate matter (PM) have been shown to cause deterioration of the symptoms of respiratory and cardiovascular disease in several regional studies. Here, we aimed to investigate the healthcare utilization of lung cancer patients associated with short-term exposure to PM at the national level in Korea. Methods: We extracted the data of 210 558 subjects over a period of 3 years (2015-2017), who were diagnosed with lung cancer before 2015 and benefited from the National Health Insurance Sharing Service. We performed the interpolation method using the geographic information system to calculate the estimated mean PM2.5 and PM10 concentrations by regions and classified three groups as high (upper 10%), intermediate (10%-90%), and low (bottom 10%) based on the mean PM mass concentrations of the month. Results: The monthly average number of outpatient visits was significantly increased in high PM2.5 urban areas (46.296 vs. 50.646, p = 0.015). In high PM2.5 nationwide regions, the monthly average number of emergency admission was significantly increased (0.528 vs. 0.785, p = 0.001). The outpatient visits tended to change with PM2.5 concentration and correlated with PM10 /PM2.5 concentrations in urban and nationwide areas. In high PM2.5 urban regions, there was a significant increase in bronchodilator prescriptions (3.102 vs. 3.758, p = 0.008). Concerning high PM2.5 nationwide regions, there were significantly increased prescriptions of antibiotics, steroids, bronchodilators, antihistamines, and mucolytics. Conclusions: This study suggests that exposure to PM2.5 is significantly associated with hospital utilization and drug prescription in lung cancer patients. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Wiley Publishing Asia Pty Ltd ; Tianjin Lung Cancer Institute | - |
dc.relation.isPartOf | THORACIC CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Air Pollutants* / adverse effects | - |
dc.subject.MESH | Air Pollutants* / analysis | - |
dc.subject.MESH | Cohort Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lung Neoplasms* / drug therapy | - |
dc.subject.MESH | Lung Neoplasms* / epidemiology | - |
dc.subject.MESH | Particulate Matter / adverse effects | - |
dc.subject.MESH | Patient Acceptance of Health Care | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.title | Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Preventive Medicine (예방의학교실) | - |
dc.contributor.googleauthor | In-Jae Oh | - |
dc.contributor.googleauthor | Cheol-Kyu Park | - |
dc.contributor.googleauthor | Kyoung-Bok Min | - |
dc.contributor.googleauthor | Jin-Young Min | - |
dc.contributor.googleauthor | Chaeuk Chung | - |
dc.contributor.googleauthor | Seong-Hoon Yoon | - |
dc.contributor.googleauthor | Changsoo Kim | - |
dc.contributor.googleauthor | Sei-Hoon Yang | - |
dc.identifier.doi | 10.1111/1759-7714.15070 | - |
dc.contributor.localId | A01042 | - |
dc.relation.journalcode | J02725 | - |
dc.identifier.eissn | 1759-7714 | - |
dc.identifier.pmid | 37567781 | - |
dc.subject.keyword | healthcare utilization | - |
dc.subject.keyword | lung cancer | - |
dc.subject.keyword | particulate matter | - |
dc.contributor.alternativeName | Kim, Chang Soo | - |
dc.contributor.affiliatedAuthor | 김창수 | - |
dc.citation.volume | 14 | - |
dc.citation.number | 27 | - |
dc.citation.startPage | 2777 | - |
dc.citation.endPage | 2784 | - |
dc.identifier.bibliographicCitation | THORACIC CANCER, Vol.14(27) : 2777-2784, 2023-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.